Why it matters
-
China is using quality-system findings to impose an immediate market access stop: The order halts not only sales but also import and use, raising the operational bar for reinstatement to demonstrated remediation of manufacturing and quality controls.
-
Remote inspections are being treated as sufficient for enforcement actions: The regulator’s reliance on a remote inspection outcome signals that off-site assessments can trigger binding restrictions, affecting compliance planning for foreign manufacturers.
Topics
World & Politics Policy & Regulation International Affairs Health & Medicine Pharma & Biotech